Pfizer Inc. announced that JAMA Dermatology has published complete results from the second Phase III monotherapy pivotal study (JADE MONO-2) of PF 04965842 (abrocitinib), an investigational oral once-daily… read more.
The pivotal Phase III clinical trial results announced show Dupixent (dupilumab) combined with standard-of-care topical corticosteroids (TCS) from Sanofi + Regeneron ,in children aged 6-11 years with uncontrolled… read more.
Novartis, announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Cosentyx (secukinumab) for the treatment… read more.
University of Queensland scientists have identified a way to help dermatologists determine a patient’s risk of developing melanoma.
Not all fats are equal in how they affect our skin, according to a new study in the Journal of Investigative Dermatology
Adding antibiotic treatment to standard drainage of simple skin abscesses appears to improve healing, researchers reported on June 29, 2017 in the NEJM/New England Journal of Medicine.
by Bruce Sylvester: Psoriasis appears to be associated with type 2 diabetes, body mass index and obesity, researchers from a twin study reported on April 27, 2016 in… read more.
by Bruce Sylvester: Treatment with nicotinamide, a form of vitamin B3, significantly lowers the risk of common, non-melanoma skin cancer in high-risk patients, researchers reported on Oct. 21,… read more.
John Ultmann Memorial Lecture / by Maria Dalby. Cutaneous lymphomas are rare conditions that require careful linking of clinical features with pathological findings for accurate diagnoses and effective… read more.
Scientists at Newcastle University have documented for the first time the DNA damage which can occur to skin across the full range of ultraviolet radiation from the sun… read more.
by Bruce Sylvester: Treatment with tofacitinib, a drug for rheumatoid arthritis, has restored skin color in a patient suffering from vitiligo, researchers reported on June 24 in JAMA Dermatology.
by Gary Finnegan: Keytruda (pembrolizumab) has been recommended by the European Medicines Agency (EMA) as monotherapy for the treatment of adult patients with advanced melanoma that cannot be… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
